Key result
Genetic deletion of Diaph1 reduced infarct size and improved contractile function after myocardial ischemia/reperfusion in mice compared to wild-type controls.
Why the study?
Does genetic deletion or silencing of Diaph1 reduce infarct size and improve contractile function in experimental models of myocardial ischemia/reperfusion injury?
Population
Wild-type mice, Diaph1 knockout mice, and H9C2 and AC16 cell lines subjected to experimental myocardial…
Comparison
Genetic deletion or silencing of Diaph1 vs Wild-type mice or control cells
Design
Preclinical
Authors
Loading...
Diaph1 deletion attenuates ischemia/reperfusion injury in mice; hypothesis-generating and leaves open translational potential in humans.
Does genetic deletion or silencing of Diaph1 reduce infarct size and improve contractile function in experimental models of myocardial ischemia/reperfusion injury?
Genetic deletion of DIAPH1 reduces infarct size and improves contractile function in experimental myocardial ischemia/reperfusion injury, highlighting it as a potential therapeutic target.
O’Shea et al. (2017) studied Myocardial ischemia/reperfusion injury. Genetic deletion or silencing of Diaph1 vs. Wild-type mice / control cells was evaluated on Infarct size and contractile function. Genetic deletion of Diaph1 reduced infarct size and improved contractile function after myocardial ischemia/reperfusion in mice compared to wild-type controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: